Abrupt ferritin increases as a marker of cancer in transfusion-dependent thalassemia

Key Points

• The aim is to evaluate abrupt ferritin increases as a potential biomarker for cancer in patients with transfusion-dependent thalassemia.
• Observed ferritin levels in transfusion-dependent thalassemia patients
• Analyzed correlations between ferritin increases and cancer diagnosis
• Compared ferritin levels with typical cancer biomarkers
• Significant increases in ferritin levels observed prior to cancer diagnosis
• Ferritin serves as a reliable marker, alongside existing cancer biomarkers
• Higher ferritin levels correlated with more advanced cancer stages